Gene · 187
Papers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Apj+ Vessels Drive Tumor Growth and Represent a Tractable Therapeutic Target. | Cell Rep | 2022 | 36198270 | PubTator, text mining | PubMed |
| High APLN Expression Predicts Poor Prognosis for Glioma Patients. | Oxid Med Cell Longev | 2022 | 36193059 | PubTator, text mining | PubMed |
| Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations. | Front Cell Neurosci | 2022 | 36187294 | PubTator, text mining | PubMed |
| Angiogenesis in gastrointestinal stromal tumors: From bench to bedside. | World J Gastrointest Oncol | 2022 | 36160752 | PubTator, text mining | PubMed |
| ELA-11 protects the heart against oxidative stress injury induced apoptosis through ERK/MAPK and PI3K/AKT signaling pathways. | Front Pharmacol | 2022 | 36160397 | PubTator, text mining | PubMed |
| MicroRNA-dependent inhibition of WEE1 controls cancer stem-like characteristics and malignant behavior in ovarian cancer. | Mol Ther Nucleic Acids | 2022 | 36159587 | PubTator, text mining | PubMed |
| Maternal obesity reduces apelin level in cord blood without altering the placental apelin/elabela-APJ system. | Placenta | 2022 | 36152345 | PubTator, text mining | PubMed |
| Upregulated Apelin Signaling in Pancreatic Cancer Activates Oncogenic Signaling Pathways to Promote Tumor Development. | Int J Mol Sci | 2022 | 36142542 | PubTator, text mining | PubMed |
| Proteomic Analysis of Effects of Spironolactone in Heart Failure With Preserved Ejection Fraction. | Circ Heart Fail | 2022 | 36126144 | PubTator, text mining | PubMed |
| Integrated analysis and identification of hub genes as novel biomarkers for Alzheimer's disease. | Front Aging Neurosci | 2022 | 36110430 | PubTator, text mining | PubMed |
| Distinct sex-specific DNA methylation differences in Alzheimer's disease. | Alzheimers Res Ther | 2022 | 36109771 | PubTator, text mining | PubMed |
| Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders. | Sci Rep | 2022 | 36104373 | PubTator, text mining | PubMed |
| Prolonged, Low-Level Exposure to the Marine Toxin, Domoic Acid, and Measures of Neurotoxicity in Nonhuman Primates. | Environ Health Perspect | 2022 | 36102641 | PubTator, text mining | PubMed |
| Possible roles of exercise and apelin against pregnancy complications. | Front Endocrinol (Lausanne) | 2022 | 36093083 | PubTator, text mining | PubMed |
| Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma. | Front Pharmacol | 2022 | 36091778 | PubTator, text mining | PubMed |
| Apelin-mediated deamidation of HMGA1 promotes tumorigenesis by enhancing SREBP1 activity and lipid synthesis. | Cancer Sci | 2022 | 36087034 | PubTator, text mining | PubMed |
| A Single-Cell Survey of Cellular Heterogeneity in Human Great Saphenous Veins. | Cells | 2022 | 36078120 | PubTator, text mining | PubMed |
| Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer. | Cancers (Basel) | 2022 | 36077676 | PubTator, text mining | PubMed |
| The Role of Blood-Derived Factors in Protection and Regeneration of Aged Tissues. | Int J Mol Sci | 2022 | 36077021 | PubTator, text mining | PubMed |
| Recent advances in molecular biology of metabolic syndrome pathophysiology: endothelial dysfunction as a potential therapeutic target. | J Diabetes Metab Disord | 2022 | 36065330 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/187/papers?page=24